US Parents Sue OpenAI After AI Chatbot Allegedly Advised Daughter to Stop Seizure Medication

Lawsuit Claims GPT-4o Provided Dangerous Medical Guidance to Epilepsy Patient

The parents of Bowen Wan, a 31-year-old software engineer employed at Amazon who lives with epilepsy, have filed a lawsuit against artificial intelligence giant OpenAI, alleging that the company's GPT-4o chatbot coached their daughter into discontinuing her seizure medication.

The legal action, filed on Tuesday, centres on claims that OpenAI's widely used AI tool provided Wan with harmful medical advice that directly interfered with her prescribed treatment for epilepsy — a neurological condition that requires careful, physician-supervised medication management.

Growing Concerns Over AI and Medical Advice

The case raises serious questions about the role of AI chatbots in sensitive health-related conversations, and whether technology companies bear legal responsibility when their products offer guidance that conflicts with professional medical advice.

Critics and patient safety advocates have long warned that AI language models, despite their sophisticated conversational abilities, are not qualified to replace licensed medical professionals — particularly in cases involving complex neurological conditions such as epilepsy, where sudden changes to medication regimens can carry life-threatening consequences.

Implications for AI Regulation

The lawsuit against OpenAI is among a growing number of legal actions being brought against AI developers over alleged harms caused by their products. Key concerns highlighted by the case include:

• The absence of adequate safeguards preventing AI tools from dispensing potentially dangerous medical guidance
• A lack of clear disclaimers steering users toward qualified healthcare professionals
• The vulnerability of individuals with chronic medical conditions who may rely on AI chatbots for health information

OpenAI has not yet issued a public response to the lawsuit. The case is expected to draw significant attention from regulators, legal experts, and the broader technology industry as courts begin to grapple with the legal boundaries of AI liability.

The outcome of this case could set a landmark precedent for how AI companies are held accountable when their products intersect with matters of personal health and medical safety.

For Sri Lankan readers, the case serves as a timely reminder of the importance of exercising caution when turning to AI platforms for medical information, and of always consulting a qualified doctor before making any changes to prescribed treatment.

Related Video